US brand comparison

Mounjaro vs Ozempic

Last updated

Mounjaro contains tirzepatide. Ozempic contains semaglutide. Compare approved uses, formulations, and self-pay prices.

Mounjaro vs Ozempic: the lowest prices now

Mounjaro vs Ozempic: active ingredients, formulations, and manufacturers
CompareMounjaroOzempic
Active ingredientTirzepatideGIP/GLP-1SemaglutideGLP-1
How it is taken

Injection

Once weekly

Injection

Once weekly

Tablet

Once daily, on an empty stomach

ManufacturerEli LillyNovo Nordisk
Direct evidence

What was actually compared

SURPASS-2 (nejm.org)

Peer-reviewed paper

Ozempic injection vs Mounjaro

Adults with type 2 diabetes inadequately controlled with metformin.

1,879 participants · 40 weeks (nejm.org/doi/full/10.1056/NEJMoa2107519) · Randomized, open-label

Mean HbA1c change (percentage points)

Treatment-regimen analysis, regardless of treatment adherence or rescue therapy.

SURPASS-2: Mean HbA1c change at 40 weeks. Treatment-regimen analysis, regardless of treatment adherence or rescue therapy.
Treatment & doseChange
Semaglutide (Ozempic)1 mg weekly injection−1.86 pp (nejm.org)
Tirzepatide (Mounjaro)5 mg weekly injection−2.01 pp (nejm.org)
Tirzepatide (Mounjaro)10 mg weekly injection−2.24 pp (nejm.org)
Tirzepatide (Mounjaro)15 mg weekly injection−2.3 pp (nejm.org)

Each tirzepatide dose lowered HbA1c more than semaglutide 1 mg in this trial.

This trial did not compare Ozempic 2 mg or tablets. HbA1c changes are percentage points, not relative percentages or weight-loss results. Study averages do not predict an individual's result.

Read the paper (nejm.org)PubMed abstract (pubmed.ncbi.nlm.nih.gov)Sponsor's analysis details (investor.lilly.com)Reviewed

Weight-loss results by formulation

Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.

Mounjaro vs Ozempic: sourced weight-loss results by formulation
CompareMounjaroOzempic
Injection evidence

No reviewed weight-loss result for this brand and formulation.

No reviewed weight-loss result for this brand and formulation.

Tablet evidence

No reviewed weight-loss result for this brand and formulation.

No reviewed weight-loss result for this brand and formulation.

Product-specific costs

Entry price and maintenance price

Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.

Mounjaro vs Ozempic: published self-pay prices by formulation
CompareMounjaroOzempic
Injection prices

Advertised entry price

from $499/28 days (lilly.com/lillydirect/mounjaro)

28-day supply (lilly.com)

≈ $534.64 per 30 days at this quoted rate

Checked on lilly.com

Mounjaro single-dose pens

LillyDirect (Eli Lilly) · maker's own price

self-pay, four weekly pens; published starting rate at each dose

Price conditions

self-pay, four weekly pens; published starting rate at each dose

The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

28-day supply

Published maintenance dose

from $499/28 days (lilly.com/lillydirect/mounjaro)

28-day supply (lilly.com)

≈ $534.64 per 30 days at this quoted rate

Checked on lilly.com

At 15 mg

Mounjaro single-dose pens

LillyDirect (Eli Lilly) · maker's own price

Published price at 15 mg

Price conditions

Published price at 15 mg

The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

28-day supply

Advertised entry price

$199/fill initially (novocare.com/pharmacy/ozempic.html)

28-day supply (novocare.com)

≈ $213.21 per 30 days at this quoted rate

Offer through

Checked on novocare.com

Ozempic pen

NovoCare (Novo Nordisk) · maker's own price

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"

Price conditions

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"

After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Published maintenance dose

$499/28 days (novocare.com/eligibility/ozempic-pharmacy.html)

28-day supply (novocare.com)

≈ $534.64 per 30 days at this quoted rate

Checked on novocare.com

At 2 mg

Ozempic pen

NovoCare (Novo Nordisk) · maker's own price

Published price at 2 mg

Price conditions

Published price at 2 mg

After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Tablet prices

No reviewed tablet formulation in this brand record.

Advertised entry price

$149/30 days (novocare.com/pharmacy/ozempic.html)

30-day supply (novocare.com)

$149 per 30 days at this quoted rate

Checked on novocare.com

Ozempic tablets

NovoCare (Novo Nordisk) · maker's own price

self-pay, 1.5 mg dose

Price conditions

self-pay, 1.5 mg dose

A prescription is required. A bottle of 30 tablets costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits.

30-day supply

Published maintenance dose

$299/30 days (novocare.com/eligibility/ozempic-pharmacy.html)

30-day supply (novocare.com)

$299 per 30 days at this quoted rate

Checked on novocare.com

At 9 mg

Ozempic tablets

NovoCare (Novo Nordisk) · maker's own price

Published price at 9 mg

Price conditions

Published price at 9 mg

A prescription is required. A bottle of 30 tablets costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits.

30 tablets per bottle. The 4 mg strength costs $199 per 30-day fill; 9 mg costs $299.

30-day supply

How these quotes are selected

For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology

From each FDA label

Mounjaro vs Ozempic side effects

Rate on the medicine, with the placebo rate in brackets, at the highest dose in each label's table. These come from separate trials, so they are not a head-to-head comparison.

Side effectMounjaro 15 mgOzempic 1 mg
Nausea18% (4%)20.3% (6.1%)
Diarrhea17% (9%)8.8% (1.9%)
Vomiting9% (2%)9.2% (2.3%)
Constipation7% (1%)3.1% (1.5%)
Abdominal pain5% (4%)5.7% (4.6%)
Indigestion5% (3%)not in table
Decreased appetite11% (1%)not in table
From FDA and CMS records

Mounjaro vs Ozempic: timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Ozempic2 mg from week 13about 1 weekNot yet: tentative onlyDec 5, 20312,044,798
Mounjaro15 mg from week 21about 5 daysNoJun 14, 20391,592,517

How long each takes · Generics and patents · Who covers what

US prescribing information

Approved uses by formulation

Eligibility, contraindications, and warnings are in each product's full prescribing information.

Mounjaro vs Ozempic: reviewed approved uses by formulation
CompareMounjaroOzempic
Injection

Glucose control in adults and children 10+ with type 2 diabetes; cardiovascular risk reduction in adults with type 2 diabetes at high cardiovascular risk.

US prescribing information (pi.lilly.com) (Mounjaro Injection prescribing information)

Reviewed Nov 4, 2026

Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease.

US prescribing information (novo-pi.com) (Ozempic Injection prescribing information)

Reviewed Nov 4, 2026

Tablet

No reviewed tablet label in this brand record. Ingredient record

Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.

US prescribing information (novo-pi.com) (Ozempic Tablet prescribing information)

Reviewed Nov 4, 2026

Full evidence and safety information

Compare the active ingredients
Updated automatically

What changed for Mounjaro and Ozempic

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Mounjaro vs Ozempic: common questions

Is Mounjaro the same as Ozempic?

No. Mounjaro contains tirzepatide and Ozempic contains semaglutide, which are different medicines.

Is Mounjaro or Ozempic better for weight loss?

SURPASS-2 compared them directly: Each tirzepatide dose lowered HbA1c more than semaglutide 1 mg in this trial. This trial did not compare Ozempic 2 mg or tablets. HbA1c changes are percentage points, not relative percentages or weight-loss results. Side effects, price and what you can stay on also decide it, with your prescriber.

Is Mounjaro or Ozempic safer?

We know of no trial set up to answer that. Stopping because of side effects, each in its own trial and not a head-to-head figure: Mounjaro 6.2% vs 2.6% placebo (15 mg) (SURMOUNT-1 (15 mg, 72 wks, obesity)) (nejm.org); Ozempic 7.0% vs 3.1% placebo (STEP 1 (2.4 mg, 68 wks, obesity)) (nejm.org). Each FDA label lists its own warnings, and which ones matter depends on your health. Side effects compared, from each FDA label

What Ozempic dose is equivalent to Mounjaro?

No FDA label sets a dose of Mounjaro that equals a dose of Ozempic, and we know of no trial that defines one. SURPASS-2 compared Semaglutide (Ozempic) at 1 mg weekly injection, Tirzepatide (Mounjaro) at 5 mg weekly injection, Tirzepatide (Mounjaro) at 10 mg weekly injection, and Tirzepatide (Mounjaro) at 15 mg weekly injection, which is a comparison of those doses, not a conversion between them. Switching is a prescriber's decision, and each label sets its own starting dose and steps. Each label's doses and steps

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.